MRI of the Pancreas. Issue 2 (17th April 2020)

• Record Type: Journal Article
• Authors: Harrington, Kate A.; Shukla‐Dave, Amita; Paudyal, Ramesh; Do, Richard K.G.
• Is Part Of: Journal of magnetic resonance imaging. Volume 53:Issue 2(2021)
• Page Start: 347
• Page End: 359
• Publication Date: 2020-04-17
• Subjects: diffusion‐weighted imaging -- dynamic contrast‐enhanced imaging -- magnetic resonance cholangiopancreatography -- pancreas -- pancreatic cancer; Magnetic resonance imaging -- Periodicals; 616
• DOI: 10.1002/jmri.27148
• Languages: English
• ISSNs: 1053-1807

Abstract

Abstract : MRI has played a critical role in the evaluation of patients with pancreatic pathologies, from screening of patients at high risk for pancreatic cancer to the evaluation of pancreatic cysts and indeterminate pancreatic lesions. The high mortality associated with pancreatic adenocarcinomas has spurred much interest in developing effective screening tools, with MRI using magnetic resonance cholangiopancreatography (MRCP) playing a central role in the hopes of identifying cancers at earlier stages amenable to curative resection. Ongoing efforts to improve the resolution and robustness of imaging of the pancreas using MRI may thus one day reduce the mortality of this deadly disease. However, the increasing use of cross‐sectional imaging has also generated a concomitant clinical conundrum: How to manage incidental pancreatic cystic lesions that are found in over a quarter of patients who undergo MRCP. Efforts to improve the specificity of MRCP for patients with pancreatic cysts and with indeterminate pancreatic masses may be achieved with continued technical advances in MRI, including diffusion‐weighted and T1 ‐weighted dynamic contrast‐enhanced MRI. However, developments in quantitative MRI of the pancreas remain challenging, due to the small size of the pancreas and its upper abdominal location, adjacent to bowel and below the diaphragm. Further research is needed to improve MRI of the pancreas as a clinical tool, to positively affect the lives of patients with pancreatic abnormalities. This review focuses on various MR techniques such as MRCP, quantitative imaging, and dynamic contrast‐enhanced imaging and their clinical applicability in the imaging of the pancreas, with an emphasis on pancreatic malignant and premalignant lesions. Level of Evidence 5 Technical Efficacy Stage 3 J. MAGN. RESON. IMAGING 2021;53:347–359.